Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared a post on LinkedIn:
“Many breast cancer patients don’t know they may have a choice.
For decades, the medical assumption was simple: more treatment equals better outcomes. Bigger surgeries. Longer radiation. More lymph nodes removed.
But the science has moved on — and for many patients, it’s telling us something different.
Less aggressive treatment can offer the same survival rate. Fewer side effects. Better quality of life. It’s called treatment de-escalation, and it’s becoming the new standard of care for the right patients.
In my latest video, I break down:
- Why “more is better” is no longer the default in breast cancer care
- What factors determine who qualifies for less aggressive treatment
- How a multidisciplinary team approach leads to better, more personalized decisions
- The questions every patient should be asking their oncology team
This isn’t about cutting corners. It’s about applying rigorous evidence to make sure patients get exactly what they need — nothing more, nothing less.
If you work in oncology, know someone navigating a breast cancer diagnosis, or simply believe patients deserve access to the latest evidence, please share this.”
Other articles featuring Francisco J. Esteva on OncoDaily.